AbbVie (ABBV) is reaffirming its expectations for a high single-digit compound annual revenue growth rate through 2029. This guidance assumes 2024 as the base year in the compound annual growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback